<DOC>
	<DOC>NCT02350205</DOC>
	<brief_summary>This clinical trial is designed to assess the safety, effectiveness and benefits of Self Assembled Skin Substitute SASS grafts as a permanent skin replacement for the treatment of full-thickness burn wounds that require permanent coverage where the availability of donor sites is limited.</brief_summary>
	<brief_title>SASS 2 : Self Assembled Skin Substitute for the Autologous Treatment of Severe Burn Wounds in Acute Stage of Burn Trauma</brief_title>
	<detailed_description />
	<mesh_term>Burns</mesh_term>
	<criteria>Deep second degree burns or third degree burns over 50% TBSA (Total body surface area) at time of recruitment or as determined by the surgeon; Limited availability of donor sites for autografts; Consent obtained by the participant or by the appropriate representative in case of inapt prospective participants or minors. Skin grafting needed only on the face, hands, feet, ears or genital area; Connective tissue diseases; Hypersensitivity to bovine proteins; Coagulation disorders prior being burned; Immunodeficiency prior being burned; Uncontrolled diabetes prior being burned; Permanent wound coverage before SASS grafts are ready;</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Burn wounds</keyword>
	<keyword>Burns</keyword>
	<keyword>Skin substitute</keyword>
</DOC>